Instil Bio, Inc. — Form 8-K Summary
Business Context and Reporting Period
Instil Bio filed this Form 8-K on June 13, 2022, reporting the entry into construction financing agreements for its manufacturing facility in Los Angeles, California. The loan agreements were executed and the loans closed on June 10, 2022.
Financing and Key Financial Terms
- Total commitment: Up to $85.0 million through a mortgage construction loan and a mezzanine construction loan.
- Initial advance: $51.5 million to reimburse construction and development costs incurred through the closing date.
- Future advances: Up to $32.9 million for remaining construction and development costs, subject to lender conditions and an approved construction budget.
- Interest: Monthly payments at a blended rate based on one-month Term SOFR plus 5.25%, subject to a SOFR floor equal to the greater of the closing-date SOFR or 0.05%.
- Interest-rate protection: The borrowers purchased interest-rate caps with a blended strike rate not exceeding 3.0%.
- Term: Three years, with two potential one-year extensions subject to conditions, including no default, a 0.25% extension fee, and achievement of a specified minimum debt yield by the property.
- Collateral and guarantees: The loans are secured by substantially all assets of the mortgage borrower, including the Los Angeles property, leases and rents, and certain contracts, as well as a pledge of 100% of the mortgage borrower’s ownership interests. Instil Bio guarantees certain obligations, including completion of construction and contribution of a specified equity amount.
Material Changes, Outlook, Risks and Unusual Items
- The transaction creates a material secured financial obligation for Instil Bio and its subsidiaries to fund development of the manufacturing facility.
- Prepayment is permitted only in whole, not in part. Prepayment before 18 months generally triggers a premium based on interest that would have accrued through the 18-month date. A sale to an unaffiliated third party during the first 12 months has a separate premium period through the 12-month date.
- No prepayment premium applies if the loans are prepaid following a sale of the property to an affiliate of Oxford Properties Group.
- The financing includes customary representations, covenants and events of default. The filing does not provide a clear estimate of total project cost, expected completion date, future interest expense, or the specified equity contribution.
- The filing contains no revenue, profit, cash-flow, margin, liquidity-balance, or operating guidance figures.
Important Facts for Investors to Verify
- Actual amounts drawn and remaining availability under the $85.0 million commitment.
- Construction progress, total remaining project costs, completion timeline and required equity contribution.
- Applicable SOFR rate, interest-rate-cap terms and resulting borrowing cost.
- Compliance with debt-yield, construction-budget and other loan covenants.
- Potential prepayment premiums, collateral exposure and the scope of Instil Bio’s guarantees.
- The complete loan agreements, which the company stated would be filed as exhibits to its Form 10-Q for the quarter ended June 30, 2022.